New England Journal of Medicine
April 13, 2017 Vol. 376 No. 15
Yellow Fever — Once Again on the Radar Screen in the Americas
Catharine I. Paules, M.D., and Anthony S. Fauci, M.D.
[See Featured Journal Content above for full text]
The Perils of Trumping Science in Global Health — The Mexico City Policy and Beyond
Nathan C. Lo, B.S., and Michele Barry, M.D.
N Engl J Med 2017; 376:1399-1401 April 13, 2017 DOI: 10.1056/NEJMp1701294
Ensuring Access to Injectable Generic Drugs — The Case of Intravesical BCG for Cntenabove for full text]Bladder Cancer
Benjamin J. Davies, M.D., Thomas J. Hwang, A.B., and Aaron S. Kesselheim, M.D., J.D., M.P.H.
N Engl J Med 2017; 376:1401-1403 April 13, 2017 DOI: 10.1056/NEJMp1615697
Limits on access to injectable generic drugs force providers to use potentially less effective alternatives, current patients to discontinue therapy, and some new patients to receive more invasive interventions. Yet shortages of important generic drugs remain frequent.